Long term follow-up protocol of Peri-operative chemotherapy with intraperitoneal and intravenous Paclitaxel plus TS-1 for serosa positive gastric cancer patients phase 2 study

Long term follow-up protocol of Peri-operative chemotherapy with intraperitoneal and intravenous Paclitaxel plus TS-1 for serosa positive gastric cancer patients phase 2 study - Long term follow-up of GAPS study

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000043646

Enrollment

Registered

2021-03-17

Start date

2019-09-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gastric cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The patients enrolled in GAPS study

Exclusion criteria

Exclusion criteria: NA

Design outcomes

Primary

Measure	Time frame
5 years overall survival rate	—

Secondary

Measure	Time frame
5 years relapse-free survival rate, 5 years PM relapse-free survival date	—

Countries

Japan

Contacts

Public ContactMotohiro Imano

Kindai Univesity Department of Surgery

imano@med.kindai.ac.jp072-366-0221

Outcome results